Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
AI Sentiment
Neutral
5/10
Updated 2 minutes ago
Updated 2 minutes ago
Updated 2 minutes ago
Updated 2 minutes ago
Real-time sector performance overview View All Sectors
Director
Avg Cost/Share
$192.28
Shares
15,000
Total Value
$2,902,551.54
Owned After
985,727
Director
Avg Cost/Share
$1.16
Shares
150,000
Total Value
$173,570.00
Owned After
402,020
Director
Avg Cost/Share
$70.57
Shares
35
Total Value
$2,470.04
Owned After
435
SEC Form 4
CHIEF BANKING OFFICER
Avg Cost/Share
$21.25
Shares
1,000
Total Value
$21,250.00
Owned After
40,701.88
SEC Form 4
Director, 10% Owner
Avg Cost/Share
$3.19
Shares
2,392
Total Value
$7,630.48
Owned After
253,399
SEC Form 4
10% Owner
Avg Cost/Share
$4.55
Shares
70
Total Value
$318.50
Owned After
2,178,794
SEC Form 4
Director
Avg Cost/Share
$1.46
Shares
1,580
Total Value
$2,306.80
Owned After
443,573
SEC Form 4
CFO
Avg Cost/Share
$1.10
Shares
20,000
Total Value
$22,000.00
Owned After
245,353
SEC Form 4
Chief Executive Officer
Avg Cost/Share
$3.09
Shares
800
Total Value
$2,472.00
Owned After
140,075
SEC Form 4
Chief Operating Officer
Avg Cost/Share
$3.25
Shares
30,769
Total Value
$99,999.25
Owned After
100,978
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Courtis Kenneth S. | AMR | Director | Aug 20, 2026 | Buy | $192.28 | 15,000 | $2,902,551.54 | 985,727 | |
| KELTER JEFFREY E | BAER | Director | Aug 20, 2026 | Buy | $1.16 | 150,000 | $173,570.00 | 402,020 | |
| WILSON DAVID | BHRB | Director | Aug 20, 2026 | Buy | $70.57 | 35 | $2,470.04 | 435 | |
| Canup Edward G | CBAN | CHIEF BANKING OFFICER | Aug 20, 2026 | Buy | $21.25 | 1,000 | $21,250.00 | 40,701.88 | |
| Levinson Sam | CLPR | Director, 10% Owner | Aug 20, 2026 | Buy | $3.19 | 2,392 | $7,630.48 | 253,399 | |
| Mink Brook Asset Management LLC | DLHC | 10% Owner | Aug 20, 2026 | Buy | $4.55 | 70 | $318.50 | 2,178,794 | |
| Sutherland Paul Howard | GAIA | Director | Aug 20, 2026 | Buy | $1.46 | 1,580 | $2,306.80 | 443,573 | |
| COBB BRIAN J. | HGBL | CFO | Aug 20, 2026 | Buy | $1.10 | 20,000 | $22,000.00 | 245,353 | |
| Genner Gareth Neville | IDAI | Chief Executive Officer | Aug 20, 2026 | Buy | $3.09 | 800 | $2,472.00 | 140,075 | |
| WILSON LIAM DANIEL | KEEL | Chief Operating Officer | Aug 20, 2026 | Buy | $3.25 | 30,769 | $99,999.25 | 100,978 |
AI Sentiment
Neutral
5/10
AI Sentiment
Neutral
5/10
AI Sentiment
Neutral
5/10
AI Sentiment
Neutral
5/10
AI Sentiment
Positive
6/10
Expert insights, market analysis, and trading strategies
When it comes to trading, the Relative Strength Index (RSI) is a crucial tool for identifying potential market reversals. Understanding RSI levels and their implications can help traders make informed decisions and improve their success rates. This guide will explain what RSI is, how it works, and specifically, what level is considered oversold.
If you're an investor or a financial enthusiast planning your trading strategy for the year 2025, one of the fundamental details you need to know is the number of stock trading days in that year. Understanding this can help optimize your trading strategies, manage your portfolio effectively, and predict market activity. In this article, we delve into how many stock trading days there are in 2025 and explore the implications for investors.
In the fast-paced world of trading, speed can be the deciding factor between capitalizing on a lucrative opportunity or missing out. For traders, having a trading platform that allows for instant deposit can greatly enhance their ability to act quickly on volatile market movements.
The Moving Average Convergence Divergence (MACD) is a powerful and widely used technical analysis tool in stock trading. It helps traders identify potential buy or sell signals based on the relationship between two moving averages of a stock's price. Whether you’re a beginner or an experienced trader, understanding MACD can significantly enhance your trading strategy.